PrymaLabs independent third-party testing protocol conducted by accredited analytical laboratories outside our production chain ensures that the purity data on your COA reflects an unbiased analytical result, not an internal quality control pass
Genetic toxicology testing returned negative results across multiple assays
Animal Studies Mouse models provide the bridge between test tubes and humans
Understanding why researchers pursued this neurotrophic compound for AD, what preclinical evidence showed, and why the clinical translation ultimately failed provides crucial context for anyone evaluating Dihexa's potential
Increased energy and focus B12 plays a key role in converting food into energy
In 2015, a Cognitive Vitality Report released by the Alzheimers Drug Discovery Foundation stated that two multi-year treatment trials had found that epithalamin, from which epitalon is isolated, had imparted no severe adverse events in older adults, and that preclinical trials supported a favorable safety profile.35 Ten years later, a systematic review published in 2025 stated that information regarding critical issues about this peptides safety is missing.1 In terms of human trials, the best case we have in support of epitalons safety is a 2002 trial involving 162 patients in which no one in the epitalon group reported serious side effects.36 At the same time, the U.S